Ufp Technologies (UFPT) EBITDA Margin (2010 - 2026)

Ufp Technologies (UFPT) posted EBITDA Margin of 15.15% for Q1 2026, up 4.94% on a QoQ basis from 14.44% in Q4 2025, and down 46.0% year-over-year from 28.06% in Q1 2025.

Ufp Technologies (UFPT) EBITDA Margin (2010 - 2026) Analysis & Trends

Ufp Technologies' EBITDA Margin history runs 17 years deep, the most recent figure standing at 15.15% for Q1 2026.

  • Quarterly EBITDA Margin fell 46.0% year-over-year to 15.15% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 15.21% (down 88.0% YoY) and the FY2025 annual result came in at 15.32%, down 72.0% from the prior year.
  • EBITDA Margin was 15.15% for Q1 2026 at Ufp Technologies, up from 14.44% in the prior quarter.
  • Across five years, EBITDA Margin topped out at 26.78% in Q3 2022 and bottomed at 8.93% in Q1 2022.
  • A 5-year average of 15.21% and a median of 15.15% in 2026 frame the typical range for EBITDA Margin.
  • Annual changes were most pronounced in 2022 — EBITDA Margin soared 1677 bps — and 2023, when it slumped 1185 bps.
  • Ufp Technologies' EBITDA Margin stood at 11.92% in 2022, then climbed by 5 bps to 12.55% in 2023, then rose by 23 bps to 15.45% in 2024, then slipped by 7 bps to 14.44% in 2025, then gained by 5 bps to 15.15% in 2026.
  • Business Quant data shows UFPT's EBITDA Margin at 15.15% in Q1 2026, 14.44% in Q4 2025, and 15.13% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA Margin (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn 12.05%
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn 15.55%
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn 19.10%
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn 21.16%
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn 28.97%
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn 21.42%
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn 6.17%
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn 10.04%
9 Smith & Nephew 25.80 Bn 25.22 Bn - -
10 Ufp Technologies 1.82 Bn 1.80 Bn 44.36 Mn 15.15%

Historic Data

Download Data
DateValue
Mar 31, 2026 15.15%
Dec 31, 2025 14.44%
Sep 30, 2025 15.13%
Jun 30, 2025 16.09%
Mar 31, 2025 15.61%
Dec 31, 2024 15.45%
Sep 30, 2024 17.06%
Jun 30, 2024 16.29%
Mar 31, 2024 15.16%
Dec 31, 2023 12.55%
Sep 30, 2023 14.93%
Jun 30, 2023 17.04%
Mar 31, 2023 13.14%
Dec 31, 2022 11.92%
Sep 30, 2022 26.78%
Jun 30, 2022 12.93%
Mar 31, 2022 8.93%
Dec 31, 2021 8.22%
Sep 30, 2021 10.01%
Jun 30, 2021 12.25%